- 专利标题: 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS
-
申请号: US13870134申请日: 2013-04-25
-
公开(公告)号: US20130237581A1公开(公告)日: 2013-09-12
- 发明人: Eric L. Stangeland , Jane Schmidt , Daisuke Roland Saito , Adam D. Hughes , Lori Jean Patterson
- 申请人: Eric L. Stangeland , Jane Schmidt , Daisuke Roland Saito , Adam D. Hughes , Lori Jean Patterson
- 申请人地址: US CA South San Francisco
- 专利权人: THERAVANCE, INC.
- 当前专利权人: THERAVANCE, INC.
- 当前专利权人地址: US CA South San Francisco
- 主分类号: A61K31/40
- IPC分类号: A61K31/40 ; A61K31/4025
摘要:
In one aspect, the invention relates to compounds of formula I: where R1-6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
公开/授权文献
- US08853255B2 3-phenoxymethylpyrrolidine compounds 公开/授权日:2014-10-07